Promising data from early stage human trials of HIV vaccine

Vaccinating against HIV is the “Holy Grail” of scientific research. However, due to the complex nature of the virus, which is among the most genetically diverse known viruses, many have considered it impossible to vaccinate against. The latest research however, reveals that a new vaccine for HIV AIDS may be closer than we think. Developed…

Read More

A potential vaccine for cancer: new data

After nearly half a century of trying to identify a vaccine that might wipe out cancers, similarly to the way vaccine targets influenza or pneumococcal pneumonia, scientists might have made a breakthrough in this arena. According to an article published in The Australian (July 7, 2017), scientists from a German biotechnology company, Biontech, as well as…

Read More

Government adds $142 million in medicines to PBS

As of July 1, 2017, the Federal Government has made AUD$142 million in new medicine listings to the Pharmaceutical Benefits Scheme (PBS), in a bid to make more medicines affordable to all Australians. Among the new listings, the PBS will fund access to vorinostat to treat patients living a subtype of blood cancer, non-Hodgkin’s lymphoma called…

Read More